Hair Contamination Leads to Hospira Aminosyn Recall

A recall has been issued for one lot of amino acid injection fluid manufactured by Hospira, after a consumer complaint was received involving at least one vial that was contaminated with hair.  

The Aminosyn II recall was announced by the FDA on August 30, after a consumer found foreign matter in the solution, which Hospira later confirmed to be a human hair follicle.

The affected lot of Aminosyn is an amino acid injection used at the user level to inject nitrogen and other vitamins for nutritional support for patients who are not capable of receiving oral nutrition is pill form.

Did You Know?

Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

Although no injuries have been reported in connection with the use of the amino acid injection fluid, injection of contaminated medications may cause a wide variety of problems depending upon a patient’s condition. According to the recall notice, patients typically may experience inflammation, phlebitis, and or low levels of allergic response but patients with more severe conditions with preexisting trauma may experience occluded capillaries and other high level risks.

The recall includes Aminosyn II 10%, Sulfite-Free, 500mL flexible containers with NDC number 0409-4164-03, Lot number 26-138-JT and has an expiration date of August 1, 2014. The affected lot was manufactured by Hospira Inc. and distributed nationwide to wholesalers, distributors, hospitals, and pharmacies between March 2013 and August 2013.

Hospira has been associated with multiple recalls over the past few years due to particulate matter contamination. Earlier this year, Hospira Inc. recalled one lot of .09% sodium chloride injection following a consumer complaint indicating particulates within the fluid which after further investigation were identified in four tested samples.

Additionally, Hospira recalled 15 lots of Pipercillin and Tazobactam injection fluids as well as their GemStar Infusion System simultaneously due to particulate matter contamination and voltage defects in the infusion system.

Those with existing product should verify the solution is part of the recalled lot and stop using/distributing the product immediately and quarantine it until they have called Stericycle at 1-866-737-4701 to arrange a return and replacement of the injection fluid.


"*" indicates required fields

Share Your Comments

I authorize the above comments be posted on this page*

Have Your Comments Reviewed by a Lawyer

Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Suboxone Settlements Failed to Compensate Users Left With Tooth Decay or Tooth loss
Suboxone Settlements Failed to Compensate Users Left With Tooth Decay or Tooth loss (Posted today)

Although Suboxone settlements have been paid to resolve antitrust violations, users who suffered damages due to tooth decay from Suboxone film must pursue individual product liability lawsuits

Bard 3DMax Hernia Mesh Lawsuit Set for Trial To Begin in April 2024
Bard 3DMax Hernia Mesh Lawsuit Set for Trial To Begin in April 2024 (Posted yesterday)

With thousands of Bard hernia mesh lawsuits pending in the federal court system, a fourth bellwether trial will be held in the spring, involving allegations that defects with Bard 3DMax caused painful and permanent injuries.